This inventor holds 1 USPTO granted patent. Top assignee: Abl Bio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Seong Gyu Seon: Innovator in Bispecific Antibodies
Introduction
Seong Gyu Seon is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His innovative work has the potential to advance therapeutic options in various medical applications.
Latest Patents
Seong Gyu Seon holds a patent for "ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF." This patent represents a crucial advancement in the treatment of diseases, showcasing his expertise in antibody engineering. He has 1 patent to his name, reflecting his commitment to innovation in the biomedical sector.
Career Highlights
Seong Gyu Seon is currently employed at Abl Bio Inc., a company known for its focus on developing innovative biopharmaceuticals. His role at Abl Bio Inc. allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.
Collaborations
Throughout his career, Seong Gyu Seon has worked alongside notable colleagues, including Sae Yi Lim and Won Jun Son. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise, leading to groundbreaking advancements in their field.
Conclusion
Seong Gyu Seon is a dedicated inventor whose work in bispecific antibodies is paving the way for new therapeutic solutions. His contributions to the field of biotechnology are noteworthy and demonstrate the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile